Works matching DE "MYELOID-derived suppressor cells"
Results: 1368
Polysaccharide Nanodonuts for Photochemotherapy‐Amplified Immunogenic Cell Death to Potentiate Systemic Antitumor Immunity Against Hepatocellular Carcinoma.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 5, p. 1, doi. 10.1002/adfm.202208486
- By:
- Publication type:
- Article
Biographies.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 2, p. 361, doi. 10.1007/s10555-023-10115-0
- Publication type:
- Article
Tumor dormancy and disease recurrence.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 1, p. 9, doi. 10.1007/s10555-023-10096-0
- By:
- Publication type:
- Article
Preface.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Role of myeloid-derived suppressor cells in tumor recurrence.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 1, p. 113, doi. 10.1007/s10555-023-10079-1
- By:
- Publication type:
- Article
Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Biography - James E. Talmadge.
- Published in:
- 2021
- Publication type:
- Announcement
Role of myeloid-derived suppressor cells in metastasis.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 2, p. 391, doi. 10.1007/s10555-020-09947-x
- By:
- Publication type:
- Article
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 2, p. 263, doi. 10.1007/s00401-023-02593-x
- By:
- Publication type:
- Article
Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 3, p. 301, doi. 10.1159/000517459
- By:
- Publication type:
- Article
МИЕЛОИДНЫЕ СУПРЕССОРНЫЕ КЛЕТКИ (MDSC) РЕГУЛИРУЮТ Т-КЛЕТОЧНЫЙ ОТВЕТ У СТАРЫХ МЫШЕЙ, ИММУНИЗИРОВАННЫХ ЦЕЛЬНОВИРИОННОЙ ВАКЦИНОЙ SARS-COV-2.
- Published in:
- Eurasian Journal of Applied Biotechnology, 2024, n. 1, p. 53
- By:
- Publication type:
- Article
亚麻籽油对多囊卵巢综合征大鼠 炎症细胞的调节作用.
- Published in:
- Modern Food Science & Technology, 2022, v. 38, n. 9, p. 27, doi. 10.13982/j.mfst.1673-9078.2022.9.1425
- By:
- Publication type:
- Article
CD39 expression on immune cells predicts methotrexate response in rheumatoid arthritis patients.
- Published in:
- Turkish Journal of Medical Sciences, 2023, v. 53, n. 5, p. 1075, doi. 10.55730/1300-0144.5672
- By:
- Publication type:
- Article
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells.
- Published in:
- Science Immunology, 2022, v. 7, n. 74, p. 1, doi. 10.1126/sciimmunol.abn6563
- By:
- Publication type:
- Article
Nano-Pulse Treatment Overcomes the Immunosuppressive Tumor Microenvironment to Elicit In Situ Vaccination Protection against Breast Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 633, doi. 10.3390/vaccines12060633
- By:
- Publication type:
- Article
Harnessing Immunity to Treat Advanced Thyroid Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 45, doi. 10.3390/vaccines12010045
- By:
- Publication type:
- Article
Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 218, doi. 10.3390/vaccines11020218
- By:
- Publication type:
- Article
Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040560
- By:
- Publication type:
- Article
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1178, doi. 10.3390/vaccines9101178
- By:
- Publication type:
- Article
Regional Delivery of Anti-PD-1 Agent for Colorectal Liver Metastases Improves Therapeutic Index and Anti-Tumor Activity.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 807, doi. 10.3390/vaccines9080807
- By:
- Publication type:
- Article
信迪利单抗注射液联合 XELOX 方案对晚期胃癌患者 PD-1, PD-L1表达 和外周血髓源性抑制细胞, 调节性 T 细胞的影响.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 14, p. 2790, doi. 10.13241/j.cnki.pmb.2024.14.037
- By:
- Publication type:
- Article
IL-6 Promotes the Proliferation and Immunosuppressive Function of Myeloid-Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5535578
- By:
- Publication type:
- Article
The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6612477
- By:
- Publication type:
- Article
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1085, doi. 10.3390/biom13071085
- By:
- Publication type:
- Article
Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 4, p. 580, doi. 10.3390/biom12040580
- By:
- Publication type:
- Article
Spatial transcriptomics deciphers the immunosuppressive microenvironment in colorectal cancer with tumour thrombus.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 12, p. 1, doi. 10.1002/ctm2.70112
- By:
- Publication type:
- Article
Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 10, p. 1, doi. 10.1002/ctm2.70048
- By:
- Publication type:
- Article
Exploring the potential role of oxidative stress‐related genes in colorectal cancer recurrence and establishing a recurrence assessment system based on single‐cell and bulk RNA‐seq analysis.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 2, p. 1, doi. 10.1002/ctm2.1577
- By:
- Publication type:
- Article
Targeting PMN‐MDSCs via CD300ld receptor for cancer immunotherapy.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1534
- By:
- Publication type:
- Article
Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathway.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 11, p. 1, doi. 10.1002/ctm2.1483
- By:
- Publication type:
- Article
LILRB3 suppresses immunity in glioma and is associated with poor prognosis.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 10, p. 1, doi. 10.1002/ctm2.1396
- By:
- Publication type:
- Article
Chrysin targets myeloid‐derived suppressor cells and enhances tumour response to anti‐PD‐1 immunotherapy.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 9, p. 1, doi. 10.1002/ctm2.1019
- By:
- Publication type:
- Article
RAI16 maintains intestinal homeostasis and inhibits NLRP3‐dependent IL‐18/CXCL16‐induced colitis and the progression of colitis‐associated colorectal cancer.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 8, p. 1, doi. 10.1002/ctm2.993
- By:
- Publication type:
- Article
3D modelling of γδ T‐cell immunotherapy.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.877
- By:
- Publication type:
- Article
FMO4 shapes immuno‐metabolic reconfiguration in hepatocellular carcinoma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 2, p. 1, doi. 10.1002/ctm2.740
- By:
- Publication type:
- Article
Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1340386
- By:
- Publication type:
- Article
Glioblastoma may evade immune surveillance through primary cilia-dependent signaling in an IL-6 dependent manner.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1279923
- By:
- Publication type:
- Article
Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1263873
- By:
- Publication type:
- Article
Exploring the regulatory role of lncRNA in cancer immunity.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1191913
- By:
- Publication type:
- Article
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1152458
- By:
- Publication type:
- Article
Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1-3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1158857
- By:
- Publication type:
- Article
Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1116016
- By:
- Publication type:
- Article
Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1166860
- By:
- Publication type:
- Article
Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1063051
- By:
- Publication type:
- Article
Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1073941
- By:
- Publication type:
- Article
Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1099811
- By:
- Publication type:
- Article
MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1199273
- By:
- Publication type:
- Article
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1161869
- By:
- Publication type:
- Article
Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1219870
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells and pulmonary hypertension.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1189195
- By:
- Publication type:
- Article